Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
暂无分享,去创建一个
R. Eastell | J. S. San Martin | S. Ralston | M. Brandi | R. Lachmann | Steven W. Ing | K. Briot | Hiroyuki Tanaka | M. Javaid | H. Yoo | Y. Takeuchi | Y. Imanishi | T. Kubota | M. Cohen-Solal | T. Weber | R. Keen | P. Kamenickỷ | K. Insogna | T. Carpenter | R. Crowley | C. Theodore-Oklota | A. Portale | Farzana Perwad | P. Pitukcheewanont | E. Imel | H. I. Cheong | M. Mealiffe | S. Jan de Beur | N. Ito | Lin Zhang | M. Cohen‐Solal